PATENT CLAIM ANALYSIS

Application Number: 15880758
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
The present invention provides oligomeric compounds. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.

Claim (Index 28):
A pharmaceutical composition comprising the compound of  claim 21  and a pharmaceutically acceptable diluent.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.4359
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14395780', '13984260', '13452703', '14137111', '14793622']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7890633347789221
- 35 USC 102 Novelty (BERT): 0.5497753049260187
- Combined Prediction Score: 0.7651345317936318
- Mean Citation Score: 366.429404
- Max Citation Score: 453.02338
- Similarity Product: 277.5653121798253

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test